Skip to main content

All Publications

Grace Wang, Miami Cancer InstituteFollow

Eribulin Plus Pembrolizumab in Patients With Metastatic Triple-Negative Breast Cancer (ENHANCE 1): A Phase 1b/2 Study

Publication Date

6-1-2021

Content Type

Article

PubMed ID:

Additional Authors:

Additional authors and institutional affiliations

Citation

Clinical Cancer Research (2021) 27(11):3061-3068.

Restricted

Available to BHSF community via local IP address or BHSF login.

Find in your library

COinS